Original Article

You have full text access to this OnlineOpen article

Delay to institution of therapy and induction of remission using single-drug or combination–disease-modifying antirheumatic drug therapy in early rheumatoid arthritis

  1. Timo Möttönen1,*,
  2. Pekka Hannonen2,
  3. Markku Korpela3,
  4. Martti Nissilä4,
  5. Hannu Kautiainen4,
  6. Jorma Ilonen5,
  7. Leena Laasonen6,
  8. Oili Kaipiainen-Seppänen7,
  9. Per Franzen8,
  10. Tapani Helve6,
  11. Juhani Koski9,
  12. Marianne Gripenberg-Gahmberg8,
  13. Riitta Myllykangas-Luosujärvi7,
  14. Marjatta Leirisalo-Repo6

Article first published online: 5 APR 2002

DOI: 10.1002/art.10135

Issue

Arthritis & Rheumatism

Arthritis & Rheumatism

Volume 46, Issue 4, pages 894–898, April 2002

Additional Information

How to Cite

Möttönen, T., Hannonen, P., Korpela, M., Nissilä, M., Kautiainen, H., Ilonen, J., Laasonen, L., Kaipiainen-Seppänen, O., Franzen, P., Helve, T., Koski, J., Gripenberg-Gahmberg, M., Myllykangas-Luosujärvi, R. and Leirisalo-Repo, M. (2002), Delay to institution of therapy and induction of remission using single-drug or combination–disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis & Rheumatism, 46: 894–898. doi: 10.1002/art.10135

Author Information

  1. 1

    Turku University Central Hospital, Turku, Finland

  2. 2

    Jyväskylä Central Hospital, Jyväskylä, Finland

  3. 3

    Tampere University Hospital, Tampere, Finland

  4. 4

    Rheumatism Foundation Hospital, Heinola, Finland

  5. 5

    Turku University, Turku, Finland

  6. 6

    Helsinki University Central Hospital, Helsinki, Finland

  7. 7

    Kuopio University Hospital, Kuopio, Finland

  8. 8

    Vastra Nyland Hospital, Tammisaari, Finland

  9. 9

    Mikkeli Central Hospital, Mikkeli, Finland

*Department of Medicine, Turku University Central Hospital, Division of Rheumatology in Paimio Hospital, Alvar Aalto way 275, FIN-21540 Paimio, Finland

Publication History

  1. Issue published online: 5 APR 2002
  2. Article first published online: 5 APR 2002
  3. Manuscript Accepted: 24 OCT 2001
  4. Manuscript Received: 25 MAY 2001

Funded by

  • Finnish Society for Rheumatology
  • Medical Research Foundation of Turku University Central Hospital

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (59K)

REFERENCES

  • 1
    Pincus T, Callahan LF. What is the natural history of rheumatoid arthritis? Rheum Dis Clin North Am 1993; 19: 123–51.
  • 2
    American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Guidelines for the management of rheumatoid arthritis. Arthritis Rheum 1996; 39: 713–22.
    Direct Link:
  • 3
    Furst DE. Rational use of disease-modifying antirheumatic drugs. Drugs 1990; 39:19–37.
  • 4
    Pincus T, O'Dell JR, Kremer JM. Combination therapy with multiple disease-modifying antirheumatic drugs in rheumatoid arthritis: a preventive strategy. Ann Intern Med 1999; 131: 768–74.
  • 5
    Luukkainen R, Kajander A, Isomaki H. Effect of gold on progression of erosions in rheumatoid arthritis: better results with early treatment. Scand J Rheumatol 1977; 6: 189–92.
  • 6
    Möttönen T, Paimela L, Ahonen J, Helve T, Hannonen P, Leirisalo-Repo M. Outcome in patients with early rheumatoid arthritis treated according to the “sawtooth” strategy. Arthritis Rheum 1996; 39: 996–1005.
    Direct Link:
  • 7
    Möttönen TT, Hannonen PJ, Boers M. Combination DMARD therapy including corticosteroids in early rheumatoid arthritis. Clin Exp Rheumatol 1999; 17: S59–65.
  • 8
    Emery P, Salmon M. Early rheumatoid arthritis: time to aim for remission? Ann Rheum Dis 1995; 54: 944–7.
  • 9
    Möttönen T, Hannonen P, Leirisalo-Repo M, Nissilä M, Kautiainen H, Korpela M, et al, the FIN-RACo trial group. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. Lancet 1999; 353: 1568–73.
  • 10
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24.
    Direct Link:
  • 11
    Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh) 1977; 18: 481–91.
  • 12
    Pinals RS, Masi AT, Larsen RA, The Subcommittee for Criteria of Remission in Rheumatoid Arthritis of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981; 24: 1308–15.
    Direct Link:
  • 13
    Fries JF, Spitz PW, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137–45.
    Direct Link:
  • 14
    Van Jaarsveld CH, Jacobs JW, van der Veen MJ, Blaauw AA, Kruize AA, Hofman DM, et al, on behalf of the Rheumatic Research Foundation Utrecht, The Netherlands. Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial. Ann Rheum Dis 2000; 59: 468–77.
  • 15
    Boers M, Verhoeven AC, Markusse HM, van de Laar MAFJ, Westhovens R, van Denderen JC, et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997; 350: 309–18.
  • 16
    Chan K-WA, Felson DT,Yood RA, Walker AM. The lag time between onset of symptoms and diagnosis of rheumatoid arthritis. Arthritis Rheum 1994; 37: 814–20.
    Direct Link:
  • 17
    Harrison B, Thomson W, Symmons D, Ollier B, Wiles N, Payton T, et al. The influence of HLA–DRB1 alleles and rheumatoid factor on disease outcome in an inception cohort of patients with early inflammatory arthritis. Arthritis Rheum 1999; 42: 2174–8.
    Direct Link:
View Full Article (HTML) Get PDF (59K)